image
Esperion Therapeutics, Inc. ESPR
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
Watchlist
$ 2.12
0.952 %
$ 418 M
Market Cap
-3.16
P/E
BALANCE SHEET
206 M ASSETS
-17.00%
Growth Rates
1Year -17.00%
3Years -16.48%
5Years 7.48%
7Years -2.47%
10Years 10.15%
661 M LIABILITIES
15.58%
Growth Rates
1Year 15.58%
3Years 13.71%
5Years 59.34%
7Years 69.25%
10Years 65.83%
-455 M EQUITY
66.05%
Growth Rates
1Year 66.05%
3Years 18.45%
5Years 5.32%
7Years -16.94%
10Years -21.72%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Esperion Therapeutics, Inc.
image
Current Assets 201 M
Cash & Short-Term Investments 82.2 M
Receivables 48.5 M
Other Current Assets 70.3 M
Non-Current Assets 4.73 M
Long-Term Investments 0
PP&E 4.68 M
Other Non-Current Assets 56 K
Current Liabilities 156 M
Accounts Payable 31.7 M
Short-Term Debt 36.4 M
Other Current Liabilities 88.1 M
Non-Current Liabilities 505 M
Long-Term Debt 505 M
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2002 Dec-2001 Dec-2000 Dec-1999
ASSETS
Cash & Cash Equivalents 82.2 124.8 208.9 305.0 166.1 37.0 34.5 38.2 77.3 85.0 56.5 6.5 1.6 40.5 70.3 70.2 5.9
Short Term Investments 0 42.1 50.4 0 34.7 99.0 165.7 173.4 134.9 20.8 3.5 0 0 4.4 0 0 0
Receivables 48.5 33.7 22.9 12.4 0 0 0 0 0 0 0 0 0 0 0 0 0
Inventory 65.6 35.2 34.4 16.1 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 4.7 10.9 12.3 12.4 10.9 6.6 3.7 2.0 2.1 0.9 0.9 0.4 0.3 0.4 1.0 1.1 0.1
Total Current Assets 201.1 246.7 329.0 345.9 211.7 142.6 203.9 213.6 214.4 106.8 60.6 7.1 1.9 45.3 71.3 71.3 6.0
PP&E 4.7 1.2 2.6 7.3 2.7 0.5 0.4 0.7 0.8 0.8 80.8 K 0.1 0.3 3.0 3.3 2.5 2.0
Intangible Assets 56 K 56 K 56 K 56 K 56 K 56 K 56 K 56 K 56 K 56 K 55.7 K 53.8 K 53.8 K 0 0 3.5 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 3.1 3.1 0 0
Long Term Investments 0 42.1 50.4 0 34.7 99.3 239.2 204.3 215.2 56.5 17.5 0 0 0 0 0 0
Other Long Term Assets 0 (42.1) 50.0 (7.4) (34.7) (99.0) (165.7) (173.4) (134.9) (20.8) 0 (0.2) 10.4 K 35 K 0.6 0.5 0
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 205.8 247.9 381.6 353.3 214.4 143.5 277.8 245.2 295.6 143.3 78.3 7.3 2.2 51.4 78.3 77.9 8.0
LIABILITIES
Accounts Payable 31.7 23.0 17.6 52.0 28.9 44.9 20.4 4.6 0.7 2.0 2.2 0.5 0.7 1.7 2.9 3.9 1.4
Short Term Debt 36.4 25.1 12.7 8.0 5.7 0 1.0 1.7 1.6 0.6 0 15.2 0 1.1 0.9 0.7 0.5
Other Current Liabilities 62.7 40.6 37.4 37.8 34.6 19.4 11.7 9.2 3.3 2.7 1.9 1.4 0.6 2.2 2.6 2.5 1.0
Total Current Liabilities 156.2 92.3 73.4 94.1 66.1 64.3 33.1 15.6 5.6 5.5 4.2 17.2 1.3 4.9 6.4 7.2 2.9
Long Term Debt 504.6 260.6 258.8 182.8 1.1 0 0 1.0 2.7 4.3 0 7.5 6.9 7.7 5.5 3.0 2.3
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 0 218.8 245.7 172.5 127.3 0 0 0 0 0 0 0 0 (7.7) (5.5) (3.0) 219
Total Liabilities 660.8 571.7 578.5 449.4 194.5 64.3 33.1 16.6 8.3 9.8 4.2 24.7 8.2 12.7 11.8 10.2 5.2
EQUITY
Common Stock 0.1 75 K 61 K 26 K 27 K 27 K 26 K 23 K 23 K 20 K 15.4 K 346 308 29 K 29 K 26 K 1.94 K
Retained Earnings (1 549.3) (1 340.0) (1 106.4) (838.8) (695.3) (598.1) (396.3) (229.2) (154.2) (104.4) (68.1) (42.0) (30.2) (94.0) (65.3) (40.4) (12.8)
Other Accumulative Comprehensive Income/Loss 0 2 K 31 K 0 23 K (0.3) (0.8) (0.2) (0.5) 59 K 3.03 K (1.2) (1.0) (3.7) (2.4) (1.3) (0.5)
Total Equity (455.0) (1 340.0) (1 106.4) (838.8) (695.3) (598.1) 244.7 228.6 287.3 133.6 74.1 (17.4) (6.1) 38.7 66.5 67.7 2.8
Total Liabilities and Equity 205.8 (768.3) (527.8) (389.4) (500.8) (533.8) 277.8 245.2 295.6 143.3 78.3 7.3 2.2 51.4 78.3 77.9 8.0
SHARES OUTSTANDING
Common Shares Outstanding 103.1 66.4 28.9 27.5 27.1 26.8 23.9 22.5 22.0 16.4 15.3 9.6 9.6 4.2 3.9 2.9 1.3